A detailed history of Pay Pay Securities Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Pay Pay Securities Corp holds 8 shares of VRTX stock, worth $3,693. This represents 0.14% of its overall portfolio holdings.

Number of Shares
8
Holding current value
$3,693
% of portfolio
0.14%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025

BUY
$396.64 - $516.74 $3,173 - $4,133
8 New
8 $3.22 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Pay Pay Securities Corp Portfolio

Follow Pay Pay Securities Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pay Pay Securities Corp, based on Form 13F filings with the SEC.

News

Stay updated on Pay Pay Securities Corp with notifications on news.